AFFINIA THERAPEUTICS INC.

Class 001: Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for use in scientific research and pharmaceutical research; Class 005: Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for medical and clinical gene therapy purposes; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Licensing of pharmaceutical intellectual property rights concerning a library of adenoassociated virus (AAV) vectors, protein sequences, nucleic acid sequences, and viral capsids for use in the research and development of gene therapy products and treatment; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; pharmaceutical engineering services, namely, pharmaceutical products development of vectors and gene therapy pharmaceutical preparations; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for medical purposes; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells; Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for use in scientfic research and pharmaceutical research; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells; "THERAPEUTICS"

THERAPEUTICS; Research and development of pharmaceutical injectables and preparations, namely, vectors and preparations for gene therapy; provision of scientific research information in the field of adeno-associated virus (AAV) vectors and preparations for gene therapy; pharmaceutical engineering services, namely, pharmaceutical products development of vectors and gene therapy pharmaceutical preparations; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells

Licensing of pharmaceutical intellectual property rights concerning a library of adeno-associated virus (AAV) vectors, protein sequences, nucleic acid sequences, and viral capsids for use in the research and development of gene therapy products and treatment; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells; "THERAPEUTICS"

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system | Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system | Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system | Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system

"THERAPEUTICS"